Sensus Healthcare Announces Retirement of Director Samuel O’Rear
BOCA RATON, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Samuel O’Rear will not stand for reelection to the Company’s Board of Directors at the Company’s 2024 annual meeting of stockholders. Mr. O’Rear has been a Director of Sensus Healthcare since 2012.
Related news for (SRTS)
- Receipt of MDSAP Certification for Sensus Healthcare’s Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts
- 24/7 Market News Snapshot 24 July, 2025 – Sensus Healthcare, Inc (NASDAQ:SRTS)
- Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence
- Sensus Healthcare Buys Back Shares
- Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration